Barry Jubraj

401 total citations
24 papers, 244 citations indexed

About

Barry Jubraj is a scholar working on Geriatrics and Gerontology, Family Practice and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Barry Jubraj has authored 24 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Geriatrics and Gerontology, 7 papers in Family Practice and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Barry Jubraj's work include Pharmaceutical Practices and Patient Outcomes (14 papers), Patient Safety and Medication Errors (6 papers) and Innovations in Medical Education (5 papers). Barry Jubraj is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (14 papers), Patient Safety and Medication Errors (6 papers) and Innovations in Medical Education (5 papers). Barry Jubraj collaborates with scholars based in United Kingdom, United States and Malta. Barry Jubraj's co-authors include Alan J Poots, Vanessa Marvin, Nina Barnett, Susie Frost, Robert Horne, John Weinman, Mitch Blair, Derek Bell, Vivian Auyeung and Angel Chater and has published in prestigious journals such as SHILAP Revista de lepidopterología, Archives of Disease in Childhood and BMJ Quality & Safety.

In The Last Decade

Barry Jubraj

22 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry Jubraj United Kingdom 9 147 71 66 66 45 24 244
Sara Modig Sweden 10 188 1.3× 81 1.1× 56 0.8× 83 1.3× 21 0.5× 22 316
Muriel Burk United States 11 153 1.0× 90 1.3× 76 1.2× 65 1.0× 45 1.0× 25 337
Anne Niquille Switzerland 10 240 1.6× 119 1.7× 101 1.5× 86 1.3× 17 0.4× 28 315
Olaf Krause Germany 9 106 0.7× 47 0.7× 76 1.2× 33 0.5× 63 1.4× 43 281
Dvora Frankenthal Israel 9 228 1.6× 122 1.7× 43 0.7× 69 1.0× 77 1.7× 15 350
Eva Drewelow Germany 10 247 1.7× 141 2.0× 129 2.0× 74 1.1× 45 1.0× 23 400
Nina Barnett United Kingdom 12 237 1.6× 122 1.7× 127 1.9× 101 1.5× 63 1.4× 44 425
Sueli Luciano Pires Brazil 10 98 0.7× 33 0.5× 66 1.0× 31 0.5× 26 0.6× 22 260
Kebede Beyene New Zealand 10 83 0.6× 83 1.2× 87 1.3× 61 0.9× 79 1.8× 47 375
Welma Wildes Amorim Brazil 9 168 1.1× 70 1.0× 54 0.8× 78 1.2× 40 0.9× 29 347

Countries citing papers authored by Barry Jubraj

Since Specialization
Citations

This map shows the geographic impact of Barry Jubraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Jubraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Jubraj more than expected).

Fields of papers citing papers by Barry Jubraj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Jubraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Jubraj. The network helps show where Barry Jubraj may publish in the future.

Co-authorship network of co-authors of Barry Jubraj

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Jubraj. A scholar is included among the top collaborators of Barry Jubraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Jubraj. Barry Jubraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Adams, Danielle & Barry Jubraj. (2023). Prescribing for people with a learning disability. Prescriber. 34(8-9). 23–27.
3.
Bates, Ian, et al.. (2021). Clinical Judgement Analysis: An innovative approach to explore the individual decision-making processes of pharmacists. Research in Social and Administrative Pharmacy. 17(12). 2097–2107. 2 indexed citations
4.
Barnett, Nina, et al.. (2021). Medication review, polypharmacy and deprescribing: Results of a pilot scoping exercise in undergraduate and postgraduate education. Pharmacy Education. 21. 126–132. 6 indexed citations
5.
Barnett, Nina, et al.. (2021). Supporting professional self‐care for PCN pharmacists. Prescriber. 32(1). 13–16. 3 indexed citations
6.
Patel, Jignesh P., et al.. (2020). Final year M.Pharm. student views and performance in objective structured clinical examinations. Pharmacy Education. 20. 295–302.
7.
Jubraj, Barry, Stephen Morris, & Michael Wilcock. (2020). How do your patients use their medicines at home and why is it important to know?. Drug and Therapeutics Bulletin. 59(1). 3–4. 1 indexed citations
8.
Garfield, Sara, Dominic Furniss, Fran Husson, et al.. (2020). How can patient-held lists of medication enhance patient safety? A mixed-methods study with a focus on user experience. BMJ Quality & Safety. 29(9). 764–773. 21 indexed citations
9.
Marvin, Vanessa & Barry Jubraj. (2018). Polypharmacy and Older People in the Hospital Environment. Public Policy & Aging Report. 28(4). 150–155. 2 indexed citations
10.
Marvin, Vanessa, et al.. (2018). Improving Pharmacists’ Targeting of Patients for Medication Review and Deprescription. SHILAP Revista de lepidopterología. 6(2). 32–32. 10 indexed citations
11.
Marvin, Vanessa, et al.. (2016). Deprescribing medicines in the acute setting to reduce the risk of falls. European Journal of Hospital Pharmacy. 24(1). 10–15. 50 indexed citations
12.
Jubraj, Barry, et al.. (2016). Why we should understand the patient experience: clinical empathy and medicines optimisation. International Journal of Pharmacy Practice. 24(5). 367–370. 17 indexed citations
13.
Jubraj, Barry, et al.. (2016). The Acute Care Assessment Tool: ‘Pharmacy ACAT. The Clinical Teacher. 14(3). 184–188. 3 indexed citations
14.
Jubraj, Barry & Mitch Blair. (2015). Use of a medication passport in a disabled child seen across many care settings. BMJ Case Reports. 2015. bcr2014208033–bcr2014208033. 11 indexed citations
15.
Duraisingham, Sai, et al.. (2015). Stopping Inappropriate Medicines in the Outpatient Setting. Research Portal (King's College London). 45. 35–41. 3 indexed citations
16.
Jubraj, Barry. (2015). ‘Dragon's Den’: an entrepreneurial method to develop innovation among junior pharmacists. European Journal of Hospital Pharmacy. 22(2). 64–65. 2 indexed citations
17.
Jubraj, Barry, et al.. (2015). A pilot survey of junior doctors’ attitudes and awareness around medication review: time to change our educational approach?. European Journal of Hospital Pharmacy. 22(4). 243–248. 38 indexed citations
18.
Davies, Graham, et al.. (2013). Use of a Multisource Feedback Tool to Develop Pharmacists in a Postgraduate Training Program. American Journal of Pharmaceutical Education. 77(3). 52–52. 8 indexed citations
19.
Jones, Sue, et al.. (2012). Development and Piloting of a Competency Framework for Pharmacy Educational and Practice Supervisors. Pharmacy Education. 12. 2 indexed citations
20.
Horne, Robert, et al.. (2001). Haemodialysis patients' beliefs about treatment: implications for adherence to medication and fluid-diet restrictions. International Journal of Pharmacy Practice. 9(3). 169–175. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026